Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva gains on earnings beat
Teva Pharmaceutical Industries Limited 2018 Q2 - Results - Earnings Call Slides (NYSE:TEVA) | Seeking Alpha
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva Pharmaceutical: Earnings Trends and Recent Developments
TEVA Stock | Teva Pharmaceuticals Q2 2020 Earnings Call - YouTube
Teva tumbles as sales and earnings underwhelm
Teva Pharmaceutical Industries Ltd. Meets Earnings Targets Despite a Mild European Winter | The Motley Fool
Teva Earnings: Is It Time to Worry? | Barron's
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Teva Pharmaceutical revenue 2006-2021 | Statista
Earnings Preview: What To Expect From Teva Pharmaceutical On Thursday
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt - MarketWatch
Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $
Teva Stock Falls After Earnings and Revenue Miss Estimates | Barron's
Teva Pharmaceutical Is in Recovery - WSJ
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror – PharmaLive
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
TEVA Gears Up to Report Q3 Earnings: What's in the Cards?
Teva earnings Q2 2018 | AlphaStreet
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations - Simply Wall St News
Teva Pharmaceutical Industries L Up 24.16% To $8.90 After Earnings Beat
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
TEVA PHARMACEUTICAL INDUSTRIES LIMITED TEVA EPS ANALYSIS
Teva Pharmaceutical beats Q4 earnings, sales estimates - Drug Delivery Business
